Back to Search
JONATHAN KOST, M.D.
M.D.
Interventional Pain Medicine Physician
NPI: 1346274792IndividualAccepts Medicare
Specialties, Licenses & Credentials
Interventional Pain Medicine PhysicianPrimary
Pain Medicine — Interventional Pain Medicine
Code: 208VP0014X
032267(CT)
Education
OTHER
Class of 1985
Research & Publications (20)
Ultrasound triggered release of cisplatin from liposomes in murine tumors.
PMID 19303426·J Control Release·2009
7-preclinical
Effect of tipranavir-ritonavir on pharmacokinetics of raltegravir.
PMID 19398643·Antimicrob Agents Chemother·2009
3-trial
Pharmacokinetics of raltegravir in individuals with UGT1A1 polymorphisms.
PMID 19279563·Clin Pharmacol Ther·2009
3-trial
Lack of a clinically important effect of moderate hepatic insufficiency and severe renal insufficiency on raltegravir pharmacokinetics.
PMID 19223645·Antimicrob Agents Chemother·2009
3-trial
Raltegravir thorough QT/QTc study: a single supratherapeutic dose of raltegravir does not prolong the QTcF interval.
PMID 18441333·J Clin Pharmacol·2008
4-observational
Lack of a significant drug interaction between raltegravir and tenofovir.
PMID 18625763·Antimicrob Agents Chemother·2008
2-rct
Smart polymers for responsive drug-delivery systems.
PMID 18534095·J Biomater Sci Polym Ed·2008
6-review
Minimal effects of ritonavir and efavirenz on the pharmacokinetics of raltegravir.
PMID 18838589·Antimicrob Agents Chemother·2008
2-rct
Modified pectin-based carrier for gene delivery: cellular barriers in gene delivery course.
PMID 18585414·J Control Release·2008
8-other
Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial.
PMID 19036425·Lancet·2008
3-trial
The effect of moxifloxacin on QTc and implications for the design of thorough QT studies.
PMID 19238652·Clin Pharmacol Ther·2008
2-rct
Minimal pharmacokinetic interaction between the human immunodeficiency virus nonnucleoside reverse transcriptase inhibitor etravirine and the integrase inhibitor raltegravir in healthy subjects.
PMID 18838586·Antimicrob Agents Chemother·2008
3-trial
Safety, tolerability, and pharmacokinetics of raltegravir after single and multiple doses in healthy subjects.
PMID 17713476·Clin Pharmacol Ther·2008
3-trial
Controlling liposomal drug release with low frequency ultrasound: mechanism and feasibility.
PMID 17319706·Langmuir·2007
8-other
Bubble growth within the skin by rectified diffusion might play a significant role in sonophoresis.
PMID 17197050·J Control Release·2007
7-preclinical
Switchable assembly of ultra narrow CdS nanowires and nanorods.
PMID 16848440·J Am Chem Soc·2006
8-other
The nature of ultrasound-SLS synergism during enhanced transdermal transport.
PMID 16165244·J Control Release·2005
7-preclinical
On-demand release by ultrasound from osmotically swollen hydrophobic matrices.
PMID 16257468·J Control Release·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 65 MEMORIAL RD
WEST HARTFORD, CT 06107 - Phone
- (860) 696-2843
Quick Facts
- NPI
- 1346274792
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 41
- Publications
- 20
Are you this provider?
Claim Your Profile